FluidForm Bio
Andrew Hudson is a Product Manager at FluidForm and Co-Founder, with experience as a Senior Development Engineer and COO. Currently pursuing a PhD in Biomedical Engineering at Carnegie Mellon University, Andrew is a member of the Regenerative Biomaterials and Therapeutics Group focusing on 3D bioprinting vascularization. Prior to this, Andrew conducted research on 3D bioprinting at both Carnegie Mellon University and RWTH Aachen University, showcasing a strong background in the field.
This person is not in any teams
This person is not in any offices
FluidForm Bio
FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications. We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options.